Pharmaceutical Transfer Pricing
The Value of Intangible Assets
At the core of this transfer pricing dispute was the relative contributions to profits of two intangible assets: marketing and R&D. Cambridge Finance Partners worked for over two years with six testifying experts including Noble Prize winner Joseph Stiglitz and Cambridge Finance Partner’s Michael Cragg. …read more
